Try our corporate solution for free!
(212) 419-8286

R&D spending by top Indian pharmaceutical companies India FY 2020

In financial year 2020 in India, Lupin had the highest amount of spendings on R&D with 225 million U.S. dollars. By contrast, the lowest was by Torrent pharma with 57 million U.S. dollars.

Pharma R&D in India

On an average, Indian pharmaceutical companies spend less than 13 percent of their annual turnover on R&D. While in fiscal year 2020, the highest expenditure on R&D was made by Lupin, Sun pharmaceuticals made promising strides towards its development plan and investments in the R&D (999279) sector and is set forth to bring focus on a variety of complex products including active pharmaceutical ingredients (APIs) along with investments in speciality pipeline.

Market outlook 

According to an OECD estimate, the pharmaceutical industry in India is expected to grow by 317 percent between 2017 and 2060, leading the global pharmaceutical market, followed by Indonesia. Currently, over 50 percent of the world’s demand for vaccines, 40 percent of demand for generic drugs in the United States and one-fourth of all medicine demand in the United Kingdom is supplied by the Indian pharmaceutical industry. With a robust presence in the generics segment, the thriving Indian pharmaceutical export market was valued at 20 billion U.S. dollars in fiscal year 2020. Other major accomplishments can be attributed to successful joint ventures within the industry and upscaling and expansion by Indian players abroad.

R&D spending of leading Indian pharmaceutical companies in India in financial year 2020

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until May 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

June 2020



Survey time period

financial year 2020

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical industry in the United Kingdom (UK)"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.